{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:36:01Z","timestamp":1791462961145,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2043424"],"award-info":[{"award-number":["2043424"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bbcan.2023.188892","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T15:09:49Z","timestamp":1680275389000},"page":"188892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vestigial-like 1 (VGLL1): An ancient co-transcriptional activator linking wing, placenta, and tumor development"],"prefix":"10.1016","volume":"1878","author":[{"given":"Heather M.","family":"Sonnemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pazdrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinler A.","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Roszik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Liz\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bbcan.2023.188892_bb0005","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1242\/dev.126.21.4807","article-title":"TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for vg function in wing formation","volume":"126","author":"Vaudin","year":"1999","journal-title":"Development"},{"issue":"8\u20139","key":"10.1016\/j.bbcan.2023.188892_bb0010","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1387\/ijdb.103080cf","article-title":"Vestigial like gene family expression in Xenopus: common and divergent features with other vertebrates","volume":"54","author":"Faucheux","year":"2010","journal-title":"Int. J. Dev. Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2023.188892_bb0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/bioinformatics\/btm076","article-title":"COBALT: constraint-based alignment tool for multiple protein sequences","volume":"23","author":"Papadopoulos","year":"2007","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.bbcan.2023.188892_bb0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.str.2012.04.004","article-title":"Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes","volume":"20","author":"Pobbati","year":"2012","journal-title":"Structure"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/cbic.201300715","article-title":"The surprising features of the TEAD4-Vgll1 protein-protein interaction","volume":"15","author":"Mesrouze","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bbcan.2023.188892_bb0030","series-title":"The Genome of Drosophila Melanogaster","author":"Zimm","year":"1992"},{"issue":"24","key":"10.1016\/j.bbcan.2023.188892_bb0035","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1101\/gad.12.24.3900","article-title":"The vestigial and scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila","volume":"12","author":"Halder","year":"1998","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.bbcan.2023.188892_bb0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s004270050201","article-title":"Specific interactions between vestigial and scalloped are required to promote wing tissue proliferation in Drosophila melanogaster","volume":"208","author":"Paumard-Rigal","year":"1998","journal-title":"Dev. Genes Evol."},{"key":"10.1016\/j.bbcan.2023.188892_bb0045","first-page":"9(7)","article-title":"Drosophila development: scalloped and vestigial take wing","author":"Bray","year":"1999","journal-title":"Curr. Biol."},{"issue":"16","key":"10.1016\/j.bbcan.2023.188892_bb0050","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1074\/jbc.272.16.10664","article-title":"The human transcription enhancer factor-1, TEF-1, can substitute for Drosophila scalloped during wingblade development","volume":"272","author":"Deshpande","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.bbcan.2023.188892_bb0055","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1101\/gad.12.24.3815","article-title":"Molecular interactions between vestigial and scalloped promote wing formation in Drosophila","volume":"12","author":"Simmonds","year":"1998","journal-title":"Genes Dev."},{"issue":"6587","key":"10.1016\/j.bbcan.2023.188892_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/382133a0","article-title":"Integration of positional signals and regulation of wing formation and identity by Drosophila vestigial gene","volume":"382","author":"Kim","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ydbio.2017.05.006","article-title":"Yorkie regulates epidermal wound healing in Drosophila larvae independently of cell proliferation and apoptosis","volume":"427","author":"Tsai","year":"2017","journal-title":"Dev. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040094","article-title":"The hippo pathway: immunity and cancer","volume":"10","author":"Taha","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41420-022-00868-y","article-title":"The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the hippo pathway","volume":"8","author":"Yao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2023.188892_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.canlet.2018.01.062","article-title":"The hippo pathway as a drug target in gastric cancer","volume":"420","author":"Qiao","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2023.188892_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.03.018","article-title":"Dysregulation of the hippo pathway signaling in aging and cancer","volume":"143","author":"Yeung","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0090","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3892\/ijo.2015.2877","article-title":"YAP\/TAZ for cancer therapy: opportunities and challenges (review)","volume":"46","author":"Guo","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2023.188892_bb0095","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.bbcan.2023.188892_bb0100","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/s41388-018-0649-6","article-title":"The complex entanglement of hippo-Yap\/Taz signaling in tumor immunity","volume":"38","author":"White","year":"2019","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188892_bb0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2017.07.007","article-title":"Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma","volume":"491","author":"Lee","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2023.188892_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11010-020-03861-0","article-title":"Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1","volume":"475","author":"Li","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-017-0421-3","article-title":"Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways","volume":"10","author":"Huang","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2023.188892_bb0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the hippo pathway in cancer, fibrosis, wound healing and regenerative medicine","volume":"19","author":"Dey","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.bbcan.2023.188892_bb0125","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev."},{"issue":"24","key":"10.1016\/j.bbcan.2023.188892_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25246001","article-title":"Protein-protein interaction disruptors of the YAP\/TAZ-TEAD transcriptional complex","volume":"25","author":"Pobbati","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bbcan.2023.188892_bb0135","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/1541-7786.MCR-17-0593","article-title":"PI3K positively regulates YAP and TAZ in mammary tumorigenesis through multiple signaling pathways","volume":"16","author":"Zhao","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2023.188892_bb0140","doi-asserted-by":"crossref","first-page":"e1900162","DOI":"10.1002\/bies.201900162","article-title":"YAP\/TAZ: drivers of tumor growth, metastasis, and resistance to therapy","volume":"42","author":"Thompson","year":"2020","journal-title":"Bioessays"},{"key":"10.1016\/j.bbcan.2023.188892_bb0145","first-page":"7","article-title":"Safety considerations in the development of hippo pathway inhibitors in cancers","author":"Kakiuchi-Kiyota","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2023.188892_bb0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ydbio.2020.12.018","article-title":"YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance","volume":"475","author":"Szulzewsky","year":"2021","journal-title":"Dev. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19141-w","article-title":"Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers","volume":"11","author":"Bradley","year":"2020","journal-title":"Nat. Commun."},{"issue":"6220","key":"10.1016\/j.bbcan.2023.188892_bb0160","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbcan.2023.188892_bb0165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Consortium","year":"2013","journal-title":"Nat. Genet."},{"issue":"D1","key":"10.1016\/j.bbcan.2023.188892_bb0170","doi-asserted-by":"crossref","first-page":"D752","DOI":"10.1093\/nar\/gky1099","article-title":"Update of the FANTOM web resource: expansion to provide additional transcriptome atlases","volume":"47","author":"Lizio","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.bbcan.2023.188892_bb0175","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2023.188892_bb0180","series-title":"Physiology","first-page":"180","article-title":"Development of structures and transport functions in the mouse placenta","author":"Watson","year":"2005"},{"key":"10.1016\/j.bbcan.2023.188892_bb0185","series-title":"Development (Cambridge)","first-page":"3650","article-title":"From the stem of the placental tree: Trophoblast stem cells and their progeny","author":"Latos","year":"2016"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188892_bb0190","doi-asserted-by":"crossref","DOI":"10.1242\/dev.156273","article-title":"Comparative analysis of mouse and human placentae across gestation reveals species-specific regulators of placental development","volume":"145","author":"Soncin","year":"2018","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.bbcan.2023.188892_bb0195","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/labinvest.3780334","article-title":"Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta","volume":"81","author":"Tarrade","year":"2001","journal-title":"Lab. Investig."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0200","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.4049\/jimmunol.1401536","article-title":"The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages","volume":"194","author":"Svensson-Arvelund","year":"2015","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.bbcan.2023.188892_bb0205","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/1541-7786.MCR-19-0375","article-title":"The emerging role of YAP\/TAZ in tumor immunity","volume":"17","author":"Pan","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2023.188892_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106939","article-title":"Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment","volume":"88","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0215","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1472-6483(10)60649-9","article-title":"Defective implantation and placentation: laying the blueprint for pregnancy complications","volume":"13","author":"Norwitz","year":"2006","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.bbcan.2023.188892_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.placenta.2019.10.006","article-title":"Transcriptomic features of trophoblast lineage cells derived from human induced pluripotent stem cells treated with BMP 4","volume":"89","author":"Tsuchida","year":"2020","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188892_bb0225","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/REP-21-0115","article-title":"Markers of equine placental differentiation: insights from gene expression studies","volume":"163","author":"Loux","year":"2022","journal-title":"Reproduction"},{"key":"10.1016\/j.bbcan.2023.188892_bb0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.theriogenology.2022.01.017","article-title":"The opposite effects of VGLL1 and VGLL4 genes on granulosa cell proliferation and apoptosis of hen ovarian prehierarchical follicles","volume":"181","author":"Sun","year":"2022","journal-title":"Theriogenology"},{"issue":"5","key":"10.1016\/j.bbcan.2023.188892_bb0235","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"10.1016\/j.bbcan.2023.188892_bb0240","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"D1","key":"10.1016\/j.bbcan.2023.188892_bb0245","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.bbcan.2023.188892_bb0250","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0b013e31825485c5","article-title":"Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status","volume":"36","author":"Thway","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"6391","key":"10.1016\/j.bbcan.2023.188892_bb0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/359162a0","article-title":"Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours","volume":"359","author":"Delattre","year":"1992","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/gcc.22823","article-title":"A novel EWSR1-VGLL1 gene fusion in a soft tissue malignant myoepithelial tumor","volume":"59","author":"Komatsu","year":"2020","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbcan.2023.188892_bb0265","series-title":"Clinical Genetics","first-page":"791","article-title":"Novel EWSR1-VGLL1 fusion in a pediatric neuroepithelial neoplasm","author":"Kundishora","year":"2020"},{"issue":"25","key":"10.1016\/j.bbcan.2023.188892_bb0270","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188892_bb0275","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/ERC-15-0038","article-title":"X-linked acrogigantism syndrome: clinical profile and therapeutic responses","volume":"22","author":"Beckers","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18500-x","article-title":"GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G s and G q\/11","volume":"11","author":"Abboud","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2023.188892_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.111091","article-title":"The X-linked acrogigantism-associated gene gpr101 is a regulator of early embryonic development and growth in zebrafish","volume":"520","author":"Trivellin","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0290","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ajhg.2022.02.002","article-title":"Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism","volume":"109","author":"Franke","year":"2022","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0295","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/ERC-13-0485","article-title":"VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer","volume":"21","author":"Castilla","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2023.188892_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121923","article-title":"PI3K\/AKT\/\u03b2-catenin signaling regulates vestigial-like 1 which predicts poor prognosis and enhances malignant phenotype in gastric cancer","volume":"11","author":"Kim","year":"2019","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.bbcan.2023.188892_bb0305","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01945-19","article-title":"The transcriptional cofactor VGLL1 drives transcription of human papillomavirus early genes via TEAD1","volume":"94","author":"Mori","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2023.188892_bb0310","series-title":"VGLL1-Directed TEAD Activation Drives Endocrine Therapy Resistance in Estrogen Receptor Positive Breast cancer","author":"Gemma","year":"2020"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0315","first-page":"26","article-title":"Epidemiology of gastric cancer: global trends, risk factors and prevention","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118892","article-title":"VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-\u03b2\/ERK\/RSK2 signaling","volume":"1868","author":"Im","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"Database issue","key":"10.1016\/j.bbcan.2023.188892_bb0325","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014: mutations, PTMs and recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0330","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12282-020-01132-w","article-title":"Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors","volume":"28","author":"Moss","year":"2021","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0335","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","article-title":"Epidemiology of triple-negative breast cancer: a review","volume":"27","author":"Howard","year":"2021","journal-title":"Cancer J."},{"key":"10.1016\/j.bbcan.2023.188892_bb0340","series-title":"Cellular Signalling","article-title":"New insights in hippo signalling alteration in human papillomavirus-related cancers","author":"Olmedo-Nieva","year":"2020"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188892_bb0345","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2023.188892_bb0350","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"issue":"7587","key":"10.1016\/j.bbcan.2023.188892_bb0355","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53","volume":"529","author":"Martinez-Zapien","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0360","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1074\/jbc.M508455200","article-title":"Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor","volume":"281","author":"Liu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0365","article-title":"Subversion of host innate immunity by human papillomavirus oncoproteins","volume":"9","author":"Lo Cigno","year":"2020","journal-title":"Pathogens (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/j.bbcan.2023.188892_bb0370","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/j.1460-2075.1992.tb05286.x","article-title":"Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells","volume":"11","author":"Ishiji","year":"1992","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbcan.2023.188892_bb0375","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4161\/cbt.23788","article-title":"Emerging roles of TEAD transcription factors and its coactivators in cancers","volume":"14","author":"Pobbati","year":"2013","journal-title":"Cancer Biol. Ther."},{"issue":"23","key":"10.1016\/j.bbcan.2023.188892_bb0380","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1158\/1078-0432.CCR-17-1004","article-title":"BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer","volume":"23","author":"Martinez","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2023.188892_bb0385","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.237222","article-title":"BMP4 promotes the metastasis of gastric cancer by inducing epithelial-mesenchymal transition via ID1","volume":"133","author":"Deng","year":"2020","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188892_bb0390","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12079-021-00649-9","article-title":"BMP4 enhances anoikis resistance and chemoresistance of breast cancer cells through canonical BMP signaling","volume":"16","author":"Sharma","year":"2022","journal-title":"J. Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188892_bb0395","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41389-021-00310-5","article-title":"TGFbeta\/cyclin D1\/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity","volume":"10","author":"Yan","year":"2021","journal-title":"Oncogenesis"},{"issue":"12","key":"10.1016\/j.bbcan.2023.188892_bb0400","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt761","article-title":"BMP4 initiates human embryonic stem cell differentiation to trophoblast","volume":"20","author":"Xu","year":"2002","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0405","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2013.06.016","article-title":"Trophoblast lineage cells derived from human induced pluripotent stem cells","volume":"436","author":"Chen","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"27","key":"10.1016\/j.bbcan.2023.188892_bb0410","doi-asserted-by":"crossref","first-page":"E3882","DOI":"10.1073\/pnas.1604747113","article-title":"Human pluripotent stem cells as a model of trophoblast differentiation in both normal development and disease","volume":"113","author":"Horii","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19","key":"10.1016\/j.bbcan.2023.188892_bb0415","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.18632\/oncotarget.24483","article-title":"Dynamic changes during the treatment of pancreatic cancer","volume":"9","author":"Wolff","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188892_bb0420","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40246-019-0220-8","article-title":"Next-generation sequencing in liquid biopsy: cancer screening and early detection","volume":"13","author":"Chen","year":"2019","journal-title":"Human Genom."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188892_bb0425","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00280-020-04189-8","article-title":"Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors","volume":"87","author":"Crook","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbcan.2023.188892_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051314","article-title":"Single-cell RNA sequencing uncovers heterogeneous circulating tumor cell subsets in breast cancer","volume":"14","author":"Papadaki","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0435","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"issue":"9","key":"10.1016\/j.bbcan.2023.188892_bb0440","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188892_bb0445","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/2159-8290.CD-20-1680","article-title":"The next decade of immune checkpoint therapy","volume":"11","author":"Sharma","year":"2021","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.bbcan.2023.188892_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092379","article-title":"Evolution of CD8(+) T cell receptor (TCR) engineered therapies for the treatment of Cancer","volume":"10","author":"Sun","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bbcan.2023.188892_bb0455","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-20-1575","article-title":"Exploiting tumor neoantigens to target cancer evolution: current challenges and promising therapeutic approaches","volume":"11","author":"Gupta","year":"2021","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188892_bb0460","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1074\/mcp.M114.042812","article-title":"Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation","volume":"14","author":"Bassani-Sternberg","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbcan.2023.188892_bb0465","author":"Ionis Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.bbcan.2023.188892_bb0470","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/lsm.21093","article-title":"Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines","volume":"43","author":"Celli","year":"2011","journal-title":"Lasers Surg. Med."},{"issue":"14","key":"10.1016\/j.bbcan.2023.188892_bb0475","doi-asserted-by":"crossref","first-page":"17726","DOI":"10.18632\/oncotarget.7394","article-title":"14-3-3\u03c3 regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbcan.2023.188892_bb0480","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/bjc.2014.95","article-title":"Phase I\/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer","volume":"110","author":"Huggett","year":"2014","journal-title":"Br. J. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X23000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X23000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:00:00Z","timestamp":1777554000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X23000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0304419X23000410"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2023.188892","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vestigial-like 1 (VGLL1): An ancient co-transcriptional activator linking wing, placenta, and tumor development","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2023.188892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"188892"}}